News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Articles|April 28, 2023

Psychiatry Comic: Batteries

Author(s)Jonny Hawkins

Always remember to think positive!

Mr Hawkins is a cartoonist whose latest book, Laughter Therapy: Good Medicine to Make Your Heart Glad, is available now.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

Comugnero Silvana/Adobe Stock

Institutional Narcissism and Renewal: Tarot Insights into Residency Training and Academic Leadership, Part 2

ByAmilcar Arnaldo Tirado, MD, MBA

March 4th 2026

In this 2-part series, a psychiatrist explores the connections between hostage films and psychiatry.

Do Hostage Films Help? Part 2: Movies and Psychiatry: Exploring Hostages & Heroics

BySharon Packer, MD

June 11th 2024

In this 2-part series, a psychiatrist explores the connections between hostage films and psychiatry.

Do Hostage Films Help? Part I: The Movies of Our Lives: How I Happened Upon Hostage Films

BySharon Packer, MD

May 20th 2024

"As we commemorate Black History Month, it is an opportune time to highlight the contributions of Black clinicians while acknowledging past and current shortcomings as well as the imperative to strive for improved equity for clinicians and patients alike."

Black History Month

ByMike Hennessy Jr

February 14th 2024

“In the realm of psychiatry, the therapeutic value of poetry lies in its ability to transcend the limitations of prose, offering a space for the unsayable and the ineffable.”

Bella, Horrida Bella

ByCaleb Rashidian, DO

January 31st 2024

Latest CME

Southern California Psychiatry Conference

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Trending on Psychiatric Times

Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder

Evidence-Based Nonpharmacological Interventions in Schizophrenia: Focus on Cognitive Impairment

Reducing Microsleeps: Oveporexton's Impact on Patient Outcomes

How Can Sleep Disruption Trigger Mood Episodes?

New Data on Alixorexton for Narcolepsy Type 2: Insights From Richard K. Bogan, MD